244 related articles for article (PubMed ID: 31556466)
1. ATP1B3 cooperates with BST-2 to promote hepatitis B virus restriction.
Zheng B; Zhang J; Zheng T; Wang H; Li Z; Huan C; Ning S; Wang Y; Zhang W
J Med Virol; 2020 Feb; 92(2):201-209. PubMed ID: 31556466
[TBL] [Abstract][Full Text] [Related]
2. ATP1B3 Protein Modulates the Restriction of HIV-1 Production and Nuclear Factor κ Light Chain Enhancer of Activated B Cells (NF-κB) Activation by BST-2.
Nishitsuji H; Sugiyama R; Abe M; Takaku H
J Biol Chem; 2016 Feb; 291(9):4754-62. PubMed ID: 26694617
[TBL] [Abstract][Full Text] [Related]
3. Osteopetrosis-Associated Transmembrane Protein 1 Recruits RNA Exosome To Restrict Hepatitis B Virus Replication.
Ma C; Xu W; Yang Q; Liu W; Xiang Q; Chen J; Zhang Q; Liu Y; Wu K; Wu J
J Virol; 2020 May; 94(11):. PubMed ID: 32188736
[TBL] [Abstract][Full Text] [Related]
4. Hepatitis B e Antigen Inhibits NF-κB Activity by Interrupting K63-Linked Ubiquitination of NEMO.
Wang Y; Cui L; Yang G; Zhan J; Guo L; Chen Y; Fan C; Liu D; Guo D
J Virol; 2019 Jan; 93(2):. PubMed ID: 30404796
[TBL] [Abstract][Full Text] [Related]
5. ATP1B3 Restricts Hepatitis B Virus Replication Via Reducing the Expression of the Envelope Proteins.
Zhang J; Zheng T; Zhou X; Wang H; Li Z; Huan C; Zheng B; Zhang W
Virol Sin; 2021 Aug; 36(4):678-691. PubMed ID: 33534085
[TBL] [Abstract][Full Text] [Related]
6. [Effect of the cytoplasmic DNA sensor DAI on replication of hepatitis B virus].
Wang Q; Li S; Huang H; Liu S; Yang Y; Yang D
Zhonghua Gan Zang Bing Za Zhi; 2015 Dec; 23(12):934-8. PubMed ID: 26739467
[TBL] [Abstract][Full Text] [Related]
7. [Role of tumor necrosis factor-alpha in the anti-HBV activity of tetracycline].
Ni Y; Jiang F; Xu H; Zeng T; Lei Y; Chen Y; Zhou Z; Ren H
Zhonghua Gan Zang Bing Za Zhi; 2014 Mar; 22(3):213-8. PubMed ID: 24824125
[TBL] [Abstract][Full Text] [Related]
8. Hepatitis B Virus-Encoded HBsAg Contributes to Hepatocarcinogenesis by Inducing the Oncogenic Long Noncoding RNA LINC00665 through the NF-κB Pathway.
Ahluwalia S; Ahmad B; Salim U; Ghosh D; Kamuju V; Ghosh A; Dabeer K; Menon MB; Vivekanandan P
Microbiol Spectr; 2022 Oct; 10(5):e0273121. PubMed ID: 35993712
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of hepatitis B virus replication by APOBEC3G in vitro and in vivo.
Lei YC; Hao YH; Zhang ZM; Tian YJ; Wang BJ; Yang Y; Zhao XP; Lu MJ; Gong FL; Yang DL
World J Gastroenterol; 2006 Jul; 12(28):4492-7. PubMed ID: 16874860
[TBL] [Abstract][Full Text] [Related]
10. HBV inhibits LPS-induced NLRP3 inflammasome activation and IL-1β production via suppressing the NF-κB pathway and ROS production.
Yu X; Lan P; Hou X; Han Q; Lu N; Li T; Jiao C; Zhang J; Zhang C; Tian Z
J Hepatol; 2017 Apr; 66(4):693-702. PubMed ID: 28027970
[TBL] [Abstract][Full Text] [Related]
11. KNK437 Inhibits Replication and Transcription of the Hepatitis B Virus.
Hu K; Huang Y; Mu J; Cheng Z; Zhu X
Bing Du Xue Bao; 2017 Jan; 33(1):24-35. PubMed ID: 30702818
[TBL] [Abstract][Full Text] [Related]
12. Synthesis and anti-hepatitis B virus activity of C4 amide-substituted isosteviol derivatives.
Huang TJ; Yang CL; Kuo YC; Chang YC; Yang LM; Chou BH; Lin SJ
Bioorg Med Chem; 2015 Feb; 23(4):720-8. PubMed ID: 25600408
[TBL] [Abstract][Full Text] [Related]
13. [The influence of HBV and its antigens on the expressions of JAK-STAT signal transduction pathway molecules and antiviral proteins of IFN alpha].
Guan SH; Yang K; Lu MJ; Lu YP; Yang DL
Zhonghua Gan Zang Bing Za Zhi; 2011 Jun; 19(6):440-4. PubMed ID: 22053375
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of hepatitis B virus expression and replication by RNA interference in HepG2.2.15.
Zhao ZF; Yang H; Han DW; Zhao LF; Zhang GY; Zhang Y; Liu MS
World J Gastroenterol; 2006 Oct; 12(37):6046-9. PubMed ID: 17009407
[TBL] [Abstract][Full Text] [Related]
15. Anti-HBV activity and mechanism of marine-derived polyguluronate sulfate (PGS) in vitro.
Wu L; Wang W; Zhang X; Zhao X; Yu G
Carbohydr Polym; 2016 Jun; 143():139-48. PubMed ID: 27083353
[TBL] [Abstract][Full Text] [Related]
16. IL-17A but not IL-22 suppresses the replication of hepatitis B virus mediated by over-expression of MxA and OAS mRNA in the HepG2.2.15 cell line.
Wang B; Zhao XP; Fan YC; Zhang JJ; Zhao J; Wang K
Antiviral Res; 2013 Mar; 97(3):285-92. PubMed ID: 23274784
[TBL] [Abstract][Full Text] [Related]
17. miR-200c targets nuclear factor IA to suppress HBV replication and gene expression via repressing HBV Enhancer I activity.
Tian H; He Z
Biomed Pharmacother; 2018 Mar; 99():774-780. PubMed ID: 29710475
[TBL] [Abstract][Full Text] [Related]
18. Role of ISGF3 in modulating the anti-hepatitis B virus activity of interferon-alpha in vitro.
Zhang Q; Wang Y; Wei L; Jiang D; Wang JH; Rao HY; Zhu L; Chen H; Fei R; Cong X
J Gastroenterol Hepatol; 2008 Nov; 23(11):1747-61. PubMed ID: 17559358
[TBL] [Abstract][Full Text] [Related]
19. Identification of BST-2/tetherin-induced hepatitis B virus restriction and hepatocyte-specific BST-2 inactivation.
Lv M; Zhang B; Shi Y; Han Z; Zhang Y; Zhou Y; Zhang W; Niu J; Yu XF
Sci Rep; 2015 Jun; 5():11736. PubMed ID: 26119070
[TBL] [Abstract][Full Text] [Related]
20. Protocatechuic acid inhibits hepatitis B virus replication by activating ERK1/2 pathway and down-regulating HNF4α and HNF1α in vitro.
Dai XQ; Cai WT; Wu X; Chen Y; Han FM
Life Sci; 2017 Jul; 180():68-74. PubMed ID: 28504115
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]